Friedrich , Beate: ”Cathepsine B, H, L und ihre Inhibitoren im Gewebe und in Zellkulturen der Prostata“

Literaturverzeichnis

1. Statistisches Jahrbuch für die Bundesrepublik Deutschland. Stuttgart : Verlag Metzler-Poeschel , 1996 :430-3.

2. Parker SL, Tong T, Bolden S, Wingo PA . "Cancer Statistics, 1997." CA Cancer J Clin 1997 ;47:5-27.

3. "Männliche Geschlechtsorgane." In: Bühling KJ, Lepenies J, Witt K, eds . Intensivkurs: Allgemeine und Spezielle Pathologie. München, Wien, Baltimore: Urban&Schwarzenberg , 1995:290-7.

4. Pienta KJ, Esper PS . "Risk factors for prostate cancer." Ann Intern Med 1993;118:793-803.

5. Hall RR . "Screening and early detection of prostate cancer will decrease morbidity and mortality from prostate cancer: the argument against." Eur Urol 1996;29 Suppl. 2:24-6.

6. Marley GM, Miller MC, Kattan MW, Zhao G, Patton KP, Vessela RL, et al. "Free and complexed prostate-specific antigen serum ratios to predict probability of primary prostate cancer and benign prostatic hyperplasia." Urology 1996;48 (6A Suppl.):16-22.

7. Waterbor JW, Bueschen AJ . "Prostate cancer screening (United States)." Cancer Causes Control 1995;6:267-74.

8. Siewinski M, Gutowicz J, Zarzycki A, Mikulewicz W . "Role of Cysteine Endopeptidases in Cancerogenesis." Cancer Biother Radiopharm 1996; 11:169-76.

9. Buck MR, Karustis DG, Day NA, Honn KV, Sloane BF . "Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues." Biochem J 1992;282:273-8.

10. Calkins CC, Sloane BF . "Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression." Biol Chem Hoppe Seyler 1995;376:71-80.

11. Guinec N, Dalet Fumeron V, Pagano M . ""In vitro" study of basement membrane degradation by the cysteine proteinases, cathepsins B, B-like and L." Biol Chem Hoppe Seyler 1993;374:1135-46.

12. Noel A, Emonard H, Polette M, Birembaut P, Foidart JM . "Role of matrix, fibroblasts and type IV collagenases in tumor progression and invasion." Pathol Res Pract 1994;190:934-41.

13. Budihna M, Strojan P, Smid L, Skrk J, Vrhovec I, Zupevc A, et al. "Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma." Biol Chem Hoppe Seyler 1996;377:385-90.

14. Kos J, Smid A, Krasovec M, Svetic B, Lenarcic B, Vrhovec I, et al. "Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer." Biol Chem Hoppe Seyler 1995; 376:401-5.

15. Sivaparvathi M, Yamamoto M, Nicolson GL, Gokaslan ZL, Fuller GN, Liotta LA, et al . "Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas." Clin Exp Metastasis 1996;14:27-34.

16. Sivaparvathi M, McCutcheon I, Sawaya R, Nicolson GL, Rao JS. "Expression of cysteine protease inhibitors in human gliomas and meningiomas." Clin Exp Metastasis 1996;14:344-50.

17. Shuja S, Murnane MJ . "Marked increases in cathepsin B and L activities distinguish papillary carcinoma of the thyroid from normal thyroid or thyroid with non-neoplastic disease." Int J Cancer 1996;66:420-6.

18. Benitez Bribiesca L, Martinez G, Ruiz MT, Gutierrez Delgado F, Utrera D . "Proteinase activity in invasive cancer of the breast." Arch Med Res 1995;26 Spec No:S163-8.

19. Budihna M, Skrk J, Zakotnik B, Gabrijelcic D, Lindtner J. "Prognostic value of total cathepsin B in invasive ductal carcinoma of the breast." Eur J Cancer 1995;31A:661-4.

20. Gabrijelcic D, Svetic B, Spaic D, Skrk J, Budihna M, Dolenc I, et al. "Cathepsins B, H and L in human breast carcinoma." Eur J Clin Chem Clin Biochem 1992;30:69-74.

21. Krepela E, Vicar J, Cernoch M. "Cathepsin B in human breast tumor tissue and cancer cells." Neoplasma 1989;36:41-52.

22. Lah TT, Kokalj Kunovar M, Drobnic Kosorok M, Babnik J, Golouh R, Vrhovec I, et al. "Cystatins and cathepsins in breast carcinoma." Biol Chem Hoppe Seyler 1992;373:595-604.

23. Lah TT, Kokalj Kunovar M, Strukelj B, Pungercar J, Barlic Maganja D, Drobnic Kosorok M, et al. "Stefins and lysosomal cathepsins B, L and D in human breast carcinoma." Int J Cancer 1992;50:36-44.

24. Lah TT, Calaf G, Kalman E, Shinde BG, Russo J, Jarosz D, et al. "Cathepsins D, B and L in breast carcinoma and in transformed human breast epithelial cells (HBEC)." Biol Chem Hoppe Seyler 1995; 376:357-63.

25. Recklies AD, Tiltman KJ, Stoker TA, Poole AR. "Secretion of proteinases from malignant and nonmalignant human breast tissue." Cancer Res 1980;40:550-6.

26. Ebert W, Knoch H, Werle B, Trefz G, Muley T, Spiess E. "Prognostic value of increased lung tumor tissue cathepsin B." Anticancer Res 1994;14:895-9.

27. Inoue T, Ishida T, Sugio K, Sugimachi K. "Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma." Cancer Res 1994;54:6133-6.

28. Werle B, Ebert W, Klein W, Spiess E. "Cathepsin B in tumors, normal tissue and isolated cells from the human lung." Anticancer Res 1994;14:1169-76.

29. Werle B, Julke B, Lah T, Spiess E, Ebert W. "Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lung." Br J Cancer 1997;75:1137-43.

30. Farinati F, Herszenyi L, Plebani M, Carraro P, De Paoli M, Cardin R, et al. "Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis." Carcinogenesis 1996;17:2581-7.

31. Plebani M, Herszenyi L, Cardin R, Roveroni G, Carraro P, Paoli MD, et al. "Cysteine and serine proteases in gastric cancer." Cancer 1995;76:367-75.

32. Watanabe M, Higashi T, Hashimoto M, Tomoda I, Tominaga S, Hashimoto N, et al. "Elevation of tissue cathepsin B and L activities in gastric cancer." Hepatogastroenterology 1987;34:120-2.

33. Campo E, Munoz J, Miquel R, Palacin A, Cardesa A, Sloane BF, et al. "Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival [see comments]." Am J Pathol 1994;145:301-9.

34. Jessup JM. "Cathepsin B and other proteases in human colorectal carcinoma [comment]." Am J Pathol 1994;145:253-62.

35. Satoh Y, Higashi T, Nouso K, Shiota T, Kinugasa N, Yoshida K, et al. "Cathepsin B in the growth of colorectal cancer: increased activity of cathepsin B in human colorectal cancer." Acta Med Okayama 1996;50:305-11.

36. Sheahan K, Shuja S, Murnane MJ. "Cysteine protease activities and tumor development in human colorectal carcinoma." Cancer Res 1989; 49:3809-14.

37. Shuja S, Sheahan K, Murnane MJ. "Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas." Int J Cancer 1991;49:341-6.

38. Adenis A, Huet G, Zerimech F, Hecquet B, Balduyck M, Peyrat JP. "Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico- pathological parameters." Cancer Lett 1995;96:267-75.

39. Keppler D, Fondaneche MC, Dalet-Fumeron V, Pagano M, Burtin P. "Immunohistochemical and Biochemical Study of a Cathepsin B-like Proteinase in Human Colonic Cancers." Cancer Res 1988;48:6855-62.

40. Corticchiato O, Cajot J-F, Abrahamson M, Chan SJ, Keppler D. "Cystatin C and Cathepsin B in Human Colon Carcinoma: Expression by Cell Lines and Matrix Degradation." Int J Cancer 1992;52:645-52.

41. Weiss RE, Liu BC, Ahlering T, Dubeau L, Droller MJ. "Mechanisms of human bladder tumor invasion: role of protease cathepsin B." J Urol 1990; 144:798-804.

42. Makarewicz R, Drewa G. "A possible application of cathepsin B activity determination for estimating the spread of the cervix uteri carcinoma." Acta Biochim Pol 1996;43:521-4.

43. Chauhan SS, Goldstein LJ, Gottesman MM. "Expression of cathepsin L in human tumors." Cancer Res 1991;51:1478-81.

44. Sinha AA, Wilson MJ, Gleason DF, Reddy PK, Sameni M, Sloane BF. "Immunohistochemical localization of cathepsin B in neoplastic human prostate." Prostate 1995;26:171-8.

45. Söderström KO, Laato M, Wu P, Hopsu Havu VK, Nurmi M, Rinne A. "Expression of acid cysteine proteinase inhibitor (ACPI) in the normal human prostate, benign prostatic hyperplasia and adenocarcinoma." Int J Cancer 1995;62:1-4.

46. Rozhin J, Wade RL, Honn KV, Sloane BF. "Membrane-associated cathepsin L: a role in metastasis of melanomas " [published erratum appears in Biochem Biophys Res Commun 1989 Dec 29;165(3):1444]. Biochem Biophys Res Commun 1989;164:556-61.

47. Sloane BF, Honn KV, Sadler JG, Turner WA, Kimpson JJ, Taylor JD. "Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential." Cancer Res 1982;42:980-6.

48. Wilson MJ. "Proteases in prostate development, function, and pathology." Microsc Res Techniq 1995;30:305-18.

49. Barrett AJ. "The cystatins: a diverse superfamily of cysteine peptidase inhibitors." Biomed Biochim Acta 1986;45:1363-74.

50. Chapman HA, Riese RJ, Shi GP. "Emerging roles for cysteine proteases in human biology." Annu Rev Physiol 1997;59:63-88.

51. Uchiyama Y, Waguri S, Sato N, Watanabe T, Ishido K, Kominami E. "Review: Cell and Tissue Distribution of Lysosomal Cysteine Proteinases, Cathepsins B, H, and L, and their Biological Roles." Acta Histochem Cytochem 1994;27:287-308.

52. Keppler D, Waridel P, Abrahamson M, Bachmann D, Berdoz J, Sordat B . "Latency of Cathepsin B secreted by human colon carcinoma cells is not linked to secretion of cystatin C and is relieved by neutrophil elastase." Biochim Biophys Acta 1994;1226:117-25.

53. Mason RW. "Species variations amongst lysosomal cysteine proteinases " [published erratum appears in Biomed Biochim Acta 1987;46(7): following 650]. Biomed Biochim Acta 1986;45:1433-40.

54. Katunuma N, Kominami E. "Lysosomal thiol cathepsins and their endogenous inhibitors." Prog Clin Biol Res 1985;180:71-9.

55. Chapman HA, Jr., Munger JS, Shi GP. "The role of thiol proteases in tissue injury and remodeling." Am J Respir Crit Care Med 1994; 150:S155-9.

56. Segundo BS, Chan SJ, Steiner DF. "Identification of cDNA clones encoding a precursor of rat liver cathepsin B." Proc Natl Acad Sci USA 1985;82:2320-4.

57. Ishido K, Imajoh S, Emori Y, Ohno S, Kawasaki H, Minami Y, et al. "Molecular cloning and sequencing of cDNA for rat cathepsin H." FEBS Lett 1987;226:33-7.

58. Ishido K, Towatari T, Imajoh S, Kawasaki H, Kominami E, Katunuma N, et al. "Molecular cloning and sequencing of cDNA for rat cathepsin L." FEBS Lett 1987;223:69-73.

59. Turk B, Bieth JG, Bjork I, Dolenc I, Turk D, Cimerman N, et al. "Regulation of the activity of lysosomal cysteine proteinases by pH-induced inactivation and/or endogenous protein inhibitors, cystatins." Biol Chem Hoppe Seyler 1995;376:225-30.

60. Schwartz MK. "Tissue cathepsins as tumor markers." Clin Chim Acta 1995;237:67-78.

61. Mort JS, Buttle DJ. "Molecules in focus: Cathepsin B." Int J Biochem Cell Biol 1997;29:715-20.

62. Koolman J, Röhm K-H. Taschenatlas der Biochemie, Stuttgart, New York: Georg Thieme Verlag, 1994:146-7.

63. Takahashi S, Murakami K, Miyake Y . "Activation of kidney prorenin by kidney cathepsin B isoenzyme." J Biochem 1982;91:419-22.

64. Bernstein HG, Kirschke H, Wiederanders B, Pollak KH, Zipress A, Rinne A. "The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease: a review." Mol Chem Neuropathol 1996;27:225-47.

65. Mantle D, Falkous G, Ishiura S, Perry RH, Perry EK. "Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease." J Neurol Sci 1995;131:65-70.

66. Kakegawa H, Nikawa T, Tagami K, Kamioka H, Sumitani K, Kawata T, et al. "Participation of cathepsin L on bone resorption." FEBS Lett 1993;321:247-50.

67. Schaefer L, Han X, Gretz N, Schaefer RM. "Alterations of cathepsins B, H and L in proximal tubules from polycystic kidneys of the Han:SPRD rat." Kidney Int 1996;50:424-31.

68. Trabandt A, Müller-Ladner U, Kriegsmann J, Gay RE, Gay S. "Expression of proteolytic cathepsins B, D, and L in periodontal gingival fibroblasts and tissues." Lab Invest 1995;73:205-12.

69. Müller-Ladner U, Gay RE, Gay S. "Cysteine proteinases in arthritis and inflammation." Perspect Drug Discov Design 1996;6:87-98.

70. Lenarcic B, Gabrijelcic D, Rozman B, Drobnic Kosorok M, Turk V. "Human cathepsin B and cysteine proteinase inhibitors (CPIs) in inflammatory and metabolic joint diseases." Biol Chem Hoppe Seyler 1988;369 Suppl:257-61.

71. Bever CT, Jr., Garver DW. "Increased cathepsin B activity in multiple sclerosis brain." J Neurol Sci 1995;131:71-3.

72. Lenarcic B, Krizaj I, Zunec P, Turk V. "Differences in specificity for the interactions of stefins A, B and D with cysteine proteinases." FEBS Lett 1996;395:113-8.

73. Leonardi A, Turk B, Turk V. "Inhibition of bovine cathepsins L and S by stefins and cystatins." Biol Chem Hoppe Seyler 1996;377:319-21.

74. Turk V, Brzin J, Longer M, Ritonja A, Eropkin M, Borchart U, et al. "Protein inhibitors of cysteine proteinases. III. Amino-acid sequence of cystatin from chicken egg white." Hoppe-Seylers Z Physiol Chem 1983;364:1487-96.

75. Henskens YM, Veerman EC, Nieuw Amerongen AV. "Cystatins in health and disease." Biol Chem Hoppe Seyler 1996;377:71-86.

76. Turk V, Brzin J, Kotnik M, Lenarcic B, Popovic T, Ritonja A, et al. "Human cysteine proteinases and their protein inhibitors stefins, cystatins and kininogens." Biomed Biochim Acta 1986;45:1375-84.

77. Barrett AJ, Rawlings ND, Davies ME, Machleidt W, Salvesen G, Turk V. "Cysteine proteinase inhibitors of the cystatin superfamily." In: Dingle JT, Gordon JL, eds. Research monographs in cell and tissue physiology. Amsterdam, New York, Oxford: Elsevier Science Publishers BV, 1986:515-69.

78. Filler G, Witt I, Priehm F, Ehrich JHH, Jung K. "Are Cystatin C and b2-microglobulin better markers than serum creatinine for prediction of a normal glomerular filtration rate?" Clin Chem 1997;43:1077-8.

79. Finney H, Newman DJ, Gruber W, Merle P, Price CP. "Initial evaluation of Cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II)." Clin Chem 1997; 43:1016-22.

80. Liotta LA, Stetler Stevenson WG. "Tumor invasion and metastasis: an imbalance of positive and negative regulation." Cancer Res 1997;51 (Suppl):5054S-9S.

81. Keppler D, Sameni M, Moin K, Mikkelsen T, Diglio CA, Sloane BF. "Tumor progression and angiogenesis: cathepsin B & Co." Biochem Cell Biol 1996;74:799-810.

82. Kohn EC. "Development and prevention of metastasis." Anticancer Res 1993;13:2553-9.

83. Leto G, Tumminello FM, Pizzolanti G, Montalto G, Soresi M, Gebbia N. "Lysosomal cathepsins B and L and Stefin A blood levels in patients with hepatocellular carcinoma and/or liver cirrhosis: potential clinical implications." Oncology 1997;54:79-83.

84. Tumminello FM, Leto G, Pizzolanti G, Candiloro V, Crescimanno M, Crosta L, et al. "Cathepsin D, B and L circulating levels as prognostic markers of malignant progression." Anticancer Res 1996;16:2315-9.

85. Assfalg Machleidt I, Jochum M, Klaubert W, Inthorn D, Machleidt W. "Enzymatically active cathepsin B dissociating from its inhibitor complexes is elevated in blood plasma of patients with septic shock and some malignant tumors." Biol Chem Hoppe Seyler 1988;369 Suppl:263-9.

86. Takahashi H, Ishidoh K, Muno D, Ohwada A, Nukiwa T, Kominami E, et al. "Cathepsin L activity is increased in alveolar macrophages and bronchoalveolar lavage fluid of smokers." Am Rev Respir Dis 1993; 147:1562-8.

87. Hirano T, Manabe T, Takeuchi S. "Serum cathepsin B levels and urinary excretion of cathepsin B in the cancer patients with remote metastasis." Cancer Lett 1993;70:41-4.

88. Kirschke H, Clausen T, Göhring B, Günther D, Heucke E, Laube F, et al. "Concentrations of lysosomal cysteine proteases are decreased in renal cell carcinoma compared with normal kidney." J Cancer Res Clin Oncol 1997;7:402-6.

89. Sinha AA, Gleason DF, Staley NA, Wilson MJ, Sameni M, Sloane BF. "Cathepsin B in angiogenesis of human prostate: an immuno-histochemical and immunoelectron microscopic analysis." Anat Rec 1995;241:353-62.

90. Sinha AA, Gleason DF, Deleon OF, Wilson MJ, Sloane BF. "Localization of a biotinylated cathepsin B oligonucleotide probe in human prostate including invasive cells and invasive edges by in situ hybridization." Anat Rec 1993;235:233-40.

91. Ross JS, Nazeer T, Figge HL, Fisher HA, Rifkin MD. "Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies." Am J Clin Pathol 1995;104:36-41.

92. Moul JW, Maygarden SJ, Ware JL, Mohler JL, Maher PD, Schenkman NS, et al. "Cathepsin D and epidermal growth factor receptor immunohistochemistry does not predict recurrence of prostate cancer in patients undergoing radical prostatectomy." J Urol 1996;155:982-5.

93. Kuczyk MA, Serth J, Bokemeyer C, Höfner K, Anton P, Thon WF, et al. "Expression der Aspartylprotease Kathepsin D an Prostatakarzinomen und benigner Prostatahyperplasie." Akt Urol 1995;26:270-4.

94. Chambon M, Rebillard X, Rochefort H, Brouillet JP, Baldet P, Guiter J, et al. "Cathepsin D cytosolic assay and immunohistochemical quantification in human prostate tumors." Prostate 1994;24:320-5.

95. UICC. TNM Klassifikation maligner Tumoren. Berlin: Springer, 1992: 141-65.

96. Cronauer MV, Klocker H, Talasz H, Geisen FH, Hobisch A, Radmeyr C, et al. "Inhibitory effects of the nucleoside ananlogue gemcitabine on prostatic cells." Prostate 1996;28:172-81.

97. Peehl DM. "Culture of Human Prostatic Epithelial Cells." In: Freshney RI, ed. Culture of Epithelial Cells. New York: Wiley-Liss, 1992:159-80.

98. Webber MM, Bello D, Quader S. "Immortalized and Tumorigenic Adult Human Prostatic Epithelial Cell Lines: Characteristics and Applications. Part 3. Oncogenes, Suppressor Genes, and Applications." Prostate 1997;30:136-42.

99. Webber MM, Bello D, Quader S. "Immortalized and Tumorigenic Adult Human Prostatic Epithelial Cell Lines: Characteristics and Applications Part 2. Tumorigenic Cell Lines." Prostate 1997;30:58-64.

100. Webber MM, Bello D, Quader S. "Immortalized and Tumorigenic Adult Human Prostatic Epithelial Cell Lines: Characteristics and Applications Part1. Cell Markers and Immortalized Nontumorigenic Cell Lines." Prostate 1997;29:386-94.

101. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. "Establishment and characterization of a human prostatic carcinoma cell line (PC-3)." Invest Urol 1979;17:16-23.

102. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF. "Isolation of a human prostate carcinoma cell line (DU 145)." Int J Cancer 1978; 21:274-81.

103. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, et al. "LNCaP model of human prostatic carcinoma." Cancer Res 1983;43:1809-18.

104. Barrett AJ, Kembhavi AA, Brown MA, Kirschke H, Knight CG, Tamai M, et al. "L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L." Biochem J 1982;201:189-98.

105. Murata M, Miyashita S, Yokoo C, Tamai M, Hanada K, Hatayama K, et al. "Novel epoxysuccinyl peptides." FEBS Lett 1991;280:307-10.

106. Barrett AJ, Kirschke H. "Cathepsin B, Cathepsin H, and Cathepsin L." In: Colowick SP, Kaplan NO, eds. Methods in Enzymology. Academic Press, 1981:535-61.

107. Barrett AJ. "Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates." Biochem J 1980;187:909-12.

108. Turk V, Kregar I. "Cathepsin B, Cathepsin H, and Cathepsin L." In: Bergemeyer HU, Bergemeyer J, Grassl M, eds. Methods of Enzymatic Analysis. Weinheim; Deerfield Beach, Florida; Basel: Verlag Chemie, 1984:195-210.

109. Riemann S, Kirschke H, Wiederanders B, Brouwer A, Shaw E, Bohley P. "Inhibition of cysteine proteinase activity by Z-Phe-Phe-diazomethane and of aspartic proteinase activity by pepstatin in different organs from some animals and isolated cells from rat liver." Acta Biol Med Ger 1982;41:83-8.

110. Bradford M. "A rapid sensitive method for the quantification of µg quantities of protein utilizing the principle of protein- dye binding." Anal Biochem 1976;72:248-54.

111. Sano M, Wada Y, Kominami E, Katunuma N, Tsukagoshi H. "Immunolocalization of Cathepsins B, H and L in skeletal muscle of x-linked muscular dystrophy (mdx) mouse." Acta Neuropathol 1988; 217:225-9.

112. Mickey DD, Stone KR, Wunderli H, Mickey GH, Vollmer RT, Paulson DF. "Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice." Cancer Res 1977;37:4049-58.

113. Ulbricht B, Hagmann W, Ebert W, Spiess E. "Differential Secretion of Cathepsins B and L from Normal and Tumor Human Lung Cells Stimulated by 12(S)- Hydroxy- eicosatetraenoic Acid." Exp Cell Res 1996;226:255-63.

114. Scaddan PB, Dufresne MJ. "Characterization of Cysteine Proteases and Their Endogenous Inhibitors in MCF-7 and Adriamycin- Resistant MCF-7 Human Breast Cancer Cells." Invas Metastasis 1993;13:301-13.

115. Koppel P, Baici A, Keist R, Matzku S, Keller R. "Cathepsin B-like proteinase as a marker for metastatic tumor cell variants." Exp Cell Biol 1984;52:293-9.

116. Sloane BF, Dunn JR, Honn KV. "Lysosomal Cathepsin B: Correlation with Metastatic Potential." Science 1981;212:1151-3.

117. Sloane BF, Rozhin J, Robinson D, Honn KV. "Role for cathepsin B and cystatins in tumor growth and progression." Biol Chem Hoppe Seyler 1990;371 Suppl:193-8.

118. Qian F, Chan SJ, Gong QM, Bajkowski AS, Steiner DF, Frankfater A. "The expression of cathepsin B and other lysosomal proteinases in normal tissues and in tumors." Biomed Biochim Acta 1991;50:531-40.

119. Bartsch G, Muller HR, Oberholzer M, Rohr HP. "Light microscopic stereological analysis of the normal prostate and of benign prostatic hyperplasia." J Urol 1979;122:487-91.

120. Marks LS, Treiger B, Dorey FJ, Fu YS, de Kernion JB. "Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands." Urology 1994;44:486-92.

121. Guenette RS, Mooibroek M, Wong K, Wong P, Tenniswood M. "Cathepsin B, a cysteine protease implicated in metastatic progression, is also expressed during regression of the rat prostate and mammary glands. " Eur J Biochem 1994;226:311-21.

122. Festuccia C, Vincentini C, di Pasquale AB, Aceto G, Zazzeroni F, Miano L, et al. "Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma." Oncol Res 1995; 7:131-8.

123. Twining SS. "Regulation of proteolytic activity in tissues." Crit Rev Biochem Mol Biol 1994;29:315-83.

124. Jung K, Lein M, Ulbrich N, Rudolph B, Henke W, Schnorr D. "Quantification of matrix metalloproteinases and tissue inhibitors of metalloproteinanses in prostatic tissue: analytical aspects." Prostate 1997;in print:

125. Weiss RE, Fair WR, Cordon-Cardo C. "Characterization of protease expression in human prostate cancer cell lines." Int J Oncol 1994;5:973-8.

126. Eastham JA, Stapleton AMF, Gousse AE, Timme TL, Yang G, Slawin KM, et al. "Association of p53 mutations with metastatic prostate cancer." Clin Cancer Res 1995;1:1111-8.

127. Jung K, Seidel B, Rudolph B, Lein M, Cronauer MV, Henke W, et al. "Antioxidant Enzymes in Malignant Prostate Cell Lines and in Primary Cultured Prostatic Cells." Free Radic Biol Med 1997;23:127-33.

128. DeClerck YA, Imren S. Protease Inhibitors: "Role and Potential Therapeutic Use in Human Cancer." Eur J Cancer 1994;30A:2170-80.

129. Bjornland K, Buo L, Kjonniksen I, Larsen M, Fodstad O, Johansen HT, et al. "Cysteine proteinase inhibitors reduce malignant melanoma cell invasion in vitro." Anticancer Res 1996;16:1627-31.


[Titelseite] [Abkürzungsverzeichnis] [1] [2] [3] [4] [5] [6] [7] [Bibliographie] [Anhang] [Selbständigkeitserklärung] [Danksagung] [Lebenslauf]

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.

DiDi DTD Version 1.1
a subset from ETD-ML Version 1.1
Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML - Version erstellt am:
Mon Jan 10 18:11:09 2000